Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28438163)

Published in Lipids Health Dis on April 24, 2017

Authors

Thuhairah Rahman1, Nur Suhana Hamzan1, Atiqah Mokhsin1, Radzi Rahmat1, Zubin Othman Ibrahim1, Rafezah Razali1, Malathi Thevarajah2, Hapizah Nawawi3,4

Author Affiliations

1: Faculty of Medicine, Universiti Teknologi MARA (UiTM), Jalan Hospital, Sungai Buloh, Selangor, Malaysia.
2: Laboratory Medicine Division, Universiti Malaya Medical Center, Kuala Lumpur, Malaysia.
3: Faculty of Medicine, Universiti Teknologi MARA (UiTM), Jalan Hospital, Sungai Buloh, Selangor, Malaysia. hapizah@salam.uitm.edu.my.
4: Institute of Pathology, Laboratory and Forensic Medicine (I-PPerForM), Universiti Teknologi MARA (UiTM), Sungai Buloh, Selangor, Malaysia. hapizah@salam.uitm.edu.my.

Articles cited by this

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79

The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07

Inflammation and atherosclerosis. Circulation (2002) 20.77

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet (1969) 5.13

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet (2001) 4.60

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet (1998) 3.97

The LDL receptor. Arterioscler Thromb Vasc Biol (2009) 3.78

Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol (1994) 3.71

Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation (1974) 3.29

Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem (1997) 3.02

Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation (2002) 2.84

Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med (2007) 2.52

The role of selectins in inflammation and disease. Trends Mol Med (2003) 2.44

E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology (1992) 2.23

Inflammatory biomarkers in coronary artery disease. J Cardiol (2009) 2.14

Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol (2004) 1.70

The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta (1986) 1.70

Integration of inflammatory signals by rolling neutrophils. Immunol Rev (2002) 1.63

Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol (2004) 1.61

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol (1997) 1.53

Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res (2004) 1.42

Coronary disease in familial hypercholesterolemia. Circulation (1967) 1.36

Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis (1976) 1.32

The risk of atherosclerotic vascular disease in subjects with xanthomatosis. Acta Med Scand (1975) 1.30

Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci (2014) 1.26

Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol (1989) 1.21

Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem (2012) 1.15

Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb Haemost (2003) 1.15

Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation (1997) 1.00

Systematic review on the association between F2-isoprostanes and cardiovascular disease. Ann Clin Biochem (2012) 0.96

Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids (2015) 0.95

A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation. Circulation (1999) 0.94

Environmental modulation of atherosclerosis end points in familial hypercholesterolemia. Atheroscler Suppl (2002) 0.92

Phosphorylation of the cytoplasmic domain of E-selectin is regulated during leukocyte-endothelial adhesion. J Immunol (1998) 0.88

Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review. Atherosclerosis (2014) 0.87

Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis (2009) 0.87

Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clin Sci (Lond) (2003) 0.84

Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population. Oman Med J (2014) 0.84

Validation of a novel ELISA for measurement of MDA-LDL in human plasma. Free Radic Biol Med (2003) 0.81

An update on familial hypercholesterolaemia. Ann Med (1999) 0.79

Soluble cell adhesion molecules s-VCAM-1 and s-ICAM-1 in subjects with familial combined hyperlipidemia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2005) 0.79

Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease. Heart (2004) 0.79

Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender. Eur Heart J (2003) 0.78

Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia. Atherosclerosis (2008) 0.78

The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits. Atherosclerosis (1993) 0.78